Macrophage inhibitory factor is produced and secreted by MEK inhibition in KRAS mutant CRC cells, and promoting intrinsic resistance through refametinib‐conditioned medium was previously investigated to resolve resistance. Here, KRAS is linked to colorectal carcinoma.